Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
NCT03613129
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Myalgic Encephalomyelitis
Chronic Fatigue Syndrome
Interventions
DRUG:
CT38
Sponsor
LUCINDA BATEMAN, MD